JPRN-UMIN000012404已完成1 期
Phase I/II trial of weekly nab-paclitaxel as second- or third-line treatment in patients with advanced non-small-cell lung cancer(OLCSG1303) - Phase I/II trial of weekly nab-paclitaxel as second- or third-line treatment in patients with advanced non-small-cell lung cancer (OLCSG1303)
Okayama Lung Cancer Study Group (OLCSG)0 个研究点目标入组 55 人开始时间: 2013年11月27日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 55
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •a case who has a history of paclitaxel or nab-paclitaxel treatment. a case with symptom(s) caused by brain metastasis or a case with meningeal dissemination. a case who has treated with thoracic radiotherapy within 4 weeks or radiotherapy for other site(s) within 2 weeks a case who has major concomitant disease as interstitial lung disease, severe cardiac disease(unstable angina pectoris, history of myocardial infarction, uncontrolled arrhythmia, severe diabetes mellitus, active infection, HBV/ HCV hepatitis or liver cirrhosis ) a case who met contraindications on a nab-PTX package leaflet.
研究者
相似试验
招募中
不适用
Phase II trial of weekly Nab-Paclitaxel as second-line chemotherapy for unrecectable or recurrent advanced gastric cancer.Advanced Gastric CancerJPRN-UMIN000015968Tottori University35
已完成
不适用
Phase 2 trial of weekly Nab paclitaxel for advanced gastric cancer patients with prior chemotherapyadvanced advanced for gastric cancer patients with prior chemotherapyJPRN-UMIN000013105Toho University Graduate School of Medicine25
已完成
2 期
Phase 2 trial of weekly Nab paclitaxel for advanced gastric cancer patients with prior chemotherapyAdvanced Gastric CancerJPRN-UMIN000011882Teikyo University School of Medicine21
招募中
不适用
Phase II study of weekly Nab-paclitaxel followed by FEC as Neoadjuvant Chemotherapy for Breast CancerBreast cancerJPRN-UMIN000005979Wakayama Medical University50
招募中
2 期
Phese 2 trial of weekly nab-paclitaxel in combination with gemcitabine in patients with metastatic breast cancer who have failed prior chemotherapyMetastatic and Recurrenced Breast CancerJPRN-UMIN000009153Toho University Omori Medical Center20